VA
ATRC icon

Vident Advisory’s AtriCure ATRC Stock Holding History

Vident Advisory’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Sell
17,181
-959
-5% -$27K ﹤0.01% 1390
2026
Q1 		$518K Buy
+18,140
New +$619K ﹤0.01% 1242

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vident Advisory's ATRC Position: Q2 2026 in Review

Vident Advisory reduced its AtriCure (ATRC) stake by 5.3% in Q2 2026, selling an estimated $27K and leaving 17,181 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Vident Advisory first reported a position in ATRC in Q1 2026 and has held it in 2 quarters since. The position peaked at $518K in Q1 2026. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Vident Advisory held 17,181 shares of AtriCure worth $481K as of Q2 2026.
  • Vident Advisory sold 959 AtriCure shares in Q2 2026, an estimated $27K.
  • AtriCure made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1390 holding.
  • Vident Advisory first reported a position in AtriCure in Q1 2026 and has held it in 2 quarters since.
  • Vident Advisory's AtriCure position peaked at $518K in Q1 2026.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.